Radioactive iodine (I-131) therapy is considered the definitive cure for feline hyperthyroidism, offering a single-treatment solution with very high success rates.
From a welfare perspective, radioiodine eliminates the stress of twice-daily medication that many cats resist. The hospitalization period is the primary welfare concern, as cats must be kept isolated without owner visits for radiation safety compliance. Cats with significant concurrent anxiety or existing kidney disease require careful candidate selection. Post-treatment hypothyroidism occurs in 2-5% of cats and requires lifelong thyroid supplementation. Overall, for cats who are good candidates, radioiodine represents the most effective path to symptom resolution and long-term quality of life.